Potential New Class of Drugs Lessen Neurodegeneration in Rat Model of PD

(June 26, 2015) – The first test in a mammalian model of a potential new class of drugs to treat Parkinson’s disease shows abatement of neurodegeneration in the brains of test rats and no significant toxicities, University of Alabama at Birmingham and Pfizer, Inc. researchers report online in The Journal of Biological Chemistry. Read more…